Harnessing stereotactic precision in the fight against primary kidney cancer: time for a randomised trial?

Daniel X. Yang; Raquibul Hannan

doi:10.1016/S1470-2045(24)00083-4

Harnessing stereotactic precision in the fight against primary kidney cancer: time for a randomised trial?

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	267-269
Number of pages	3
Journal	The Lancet Oncology
Volume	25
Issue number	3
DOIs	https://doi.org/10.1016/S1470-2045(24)00083-4
State	Published - Mar 2024

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(24)00083-4

Cite this

@article{08baac3a829f40529cf5c0eccaa29663,

title = "Harnessing stereotactic precision in the fight against primary kidney cancer: time for a randomised trial?",

author = "Yang, {Daniel X.} and Raquibul Hannan",

year = "2024",

month = mar,

doi = "10.1016/S1470-2045(24)00083-4",

language = "English (US)",

volume = "25",

pages = "267--269",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "3",

}

TY - JOUR

T1 - Harnessing stereotactic precision in the fight against primary kidney cancer

T2 - time for a randomised trial?

AU - Yang, Daniel X.

AU - Hannan, Raquibul

PY - 2024/3

Y1 - 2024/3

UR - http://www.scopus.com/inward/record.url?scp=85186322789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85186322789&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(24)00083-4

DO - 10.1016/S1470-2045(24)00083-4

M3 - Comment/debate

C2 - 38423040

AN - SCOPUS:85186322789

SN - 1470-2045

VL - 25

SP - 267

EP - 269

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 3

ER -

Harnessing stereotactic precision in the fight against primary kidney cancer: time for a randomised trial?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this